Helixgate

Helixgate

Uncategorized

The State of Multiomics & NGS

Published

on

Broadcast Date: 

  • Time: 

Next-generation sequencing (NGS) has never been cheaper or more accessible. In turn, spatial biology, single-cell, and proteomics are fueling exciting advances in biology. The rapidly declining cost of whole-genome sequencing is empowering researchers to ask questions that were beyond reach just a few years ago. 

In The State of Multiomics & NGS virtual summit—sponsored exclusively by Illumina—GEN invites you to watch a superb line-up of presenters covering key topics in the world of multiomics, spatial biology, and NGS. This year’s summit features a broad selection of talks and panel discussions from renowned experts that offers our audience rich insights into the latest NGS platforms, spatial biology applications in neurodegenerative diseases and cell biology, and a critical look at data management challenges and solutions.

Among the highlights are:

  • A keynote presentation from Miranda Orr, PhD, on the use of spatial biology in studying Alzheimer’s and other neurodegenerative diseases
  • A deep dive into the latest NGS platforms and applications with veteran genomics analysts Keith Robison, PhD, and Shawn Baker, PhD
  • Modeling the proteome architecture of human cells with Noorsher Ahmed, PhD (Lundberg lab)
  • Chris Dwan on data management strategies for multiomics
  • And a sponsored breakout conversation featuring Illumina’s chief medical officer, Eric Green, MD, PhD, and cancer biologist Bodour Salhia, PhD (USC)

We look forward to seeing you on April 29. Registration is absolutely free! !

Guest Speakers Include

The State of Multiomics & NGS speakers

illumina logo

The post The State of Multiomics & NGS appeared first on GEN – Genetic Engineering and Biotechnology News.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Three gene therapy pioneers just won the Breakthrough Prize. This is their story

Published

on

A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field …

Continue Reading

Uncategorized

How Trump is pushing psychedelics reform through the health agencies

Published

on

WASHINGTON — President Trump moved on Saturday to “reverse the crisis of serious mental illness in America” by boosting access to psychedelic drugs in clinical settings. In an executive order, he directed the federal government to rush access to treatments and reevaluate their status as controlled substances.

The order directs the Food and Drug Administration to expedite some psychedelics as breakthrough drugs, as well as allowing them to be used through right-to-try legislation, which allow terminally ill patients to try experimental drugs outside of usual regulatory pathways.

Read the rest…

Continue Reading

Uncategorized

Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role

The nomination of a new leader for the Centers for Disease Control and Prevention — one who has scientific credentials and no public ties to the anti-vaccine movement — has generated sighs of relief in the public health world. 

As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.”

Read the rest…

Read More

Published

on

The nomination of a new leader for the Centers for Disease Control and Prevention — one who has scientific credentials and no public ties to the anti-vaccine movement — has generated sighs of relief in the public health world. 

As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.”

Read the rest…

Read More

Continue Reading
Advertisement

Trending